Roche's Genentech Names Alexander Hardy Chief Executive
January 24 2019 - 11:25AM
Dow Jones News
By Michael Dabaie
Roche Holding AG's (RHHBY) Genentech on Thursday named Alexander
Hardy chief executive effective March 1.
Mr. Hardy succeeds Bill Anderson, who was recently appointed
chief executive of Roche Pharmaceuticals. Roche last month said it
appointed Mr. Anderson CEO of Roche Pharmaceuticals, replacing
Daniel O'Day, who was named chief executive of Gilead Sciences Inc.
(GILD).
Mr. Hardy first joined Genentech in 2005, where he held several
senior management positions. In 2014, he became head of Asia
Pacific for Roche Pharmaceuticals and is currently head of global
product strategy.
Write to Michael Dabaie at michael.dabaie@wsj.com
(END) Dow Jones Newswires
January 24, 2019 11:10 ET (16:10 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
Roche (QX) (USOTC:RHHBY)
Historical Stock Chart
From Aug 2024 to Sep 2024
Roche (QX) (USOTC:RHHBY)
Historical Stock Chart
From Sep 2023 to Sep 2024